Rewired chromatin structure and epigenetic gene dysregulation during HTLV-1 infection to leukemogenesis
- PMID: 39561277
- PMCID: PMC11786301
- DOI: 10.1111/cas.16388
Rewired chromatin structure and epigenetic gene dysregulation during HTLV-1 infection to leukemogenesis
Abstract
Human T-cell leukemia virus type 1 (HTLV-1) broadly impacts host genes, affecting the infected cell population and inducing the development of a disease with a poor prognosis, adult T-cell leukemia-lymphoma (ATL). This study aimed to provide a comprehensive epigenomic characterization of the infected cell population and evaluated the transcriptome and chromatin structures of peripheral blood cells in HTLV-1-infected individuals using RNA sequencing (RNA-seq) and assay for transposase-accessible chromatin sequencing (ATAC-seq). The infected cells showed significant changes in gene expression patterns from the polyclonal stage and before ATL onset while demonstrating similarities to tumor-forming ATL cells. These similarities were a result of large-scale open chromatin changes, supporting the independent early formation of epigenomic aberrations as an underlying mechanism for later clonal propagation. This study also demonstrated that HTLV-1 Tax directly affects the host chromatin structure, thereby developing fundamental epigenomic characteristics. Several Tax target genes, including the RASGRP3-ERK pathway, were recognized, indicating an impact on signaling pathways. This genome-wide variability in chromatin structural property is a novel feature of HTLV-1 infection and may contribute to pathogenic mechanisms. In addition, it has crucial implications for better understanding the impact of HTLV-1 on the host genome and identifying novel therapeutic targets.
Keywords: ATL; HTLV‐1; chromatin; epigenetics; gene expression.
© 2024 The Author(s). Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.
Conflict of interest statement
The authors declare no conflict of interest.
Figures





Similar articles
-
Adult T-cell leukemia-lymphoma as a viral disease: Subtypes based on viral aspects.Cancer Sci. 2021 May;112(5):1688-1694. doi: 10.1111/cas.14869. Epub 2021 Mar 30. Cancer Sci. 2021. PMID: 33630351 Free PMC article. Review.
-
CD69 overexpression by human T-cell leukemia virus type 1 Tax transactivation.Biochim Biophys Acta. 2013 Jun;1833(6):1542-52. doi: 10.1016/j.bbamcr.2013.03.006. Epub 2013 Mar 16. Biochim Biophys Acta. 2013. PMID: 23507197
-
Integrative analysis of ATAC-seq and RNA-seq for cells infected by human T-cell leukemia virus type 1.PLoS Comput Biol. 2025 Jan 2;21(1):e1012690. doi: 10.1371/journal.pcbi.1012690. eCollection 2025 Jan. PLoS Comput Biol. 2025. PMID: 39746113 Free PMC article.
-
Polycomb-dependent epigenetic landscape in adult T-cell leukemia.Blood. 2016 Apr 7;127(14):1790-802. doi: 10.1182/blood-2015-08-662593. Epub 2016 Jan 15. Blood. 2016. PMID: 26773042
-
Adult T-cell leukemia: molecular basis for clonal expansion and transformation of HTLV-1-infected T cells.Blood. 2017 Mar 2;129(9):1071-1081. doi: 10.1182/blood-2016-09-692574. Epub 2017 Jan 23. Blood. 2017. PMID: 28115366 Free PMC article. Review.
Cited by
-
The role of pioneering transcription factors, chromatin accessibility and epigenetic reprogramming in oncogenic viruses.Front Microbiol. 2025 Jun 16;16:1602497. doi: 10.3389/fmicb.2025.1602497. eCollection 2025. Front Microbiol. 2025. PMID: 40589575 Free PMC article. Review.
-
Bidirectional anti-tumor and immunological strategies by targeting GARP-TGF-β axis in adult T-cell leukemia/lymphoma.Leukemia. 2025 Aug 4. doi: 10.1038/s41375-025-02725-0. Online ahead of print. Leukemia. 2025. PMID: 40759773
References
-
- Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T‐cell leukemia: clinical and hematologic features of 16 cases. Blood. 1977;50(3):481‐492. - PubMed
MeSH terms
Substances
Grants and funding
- JP22H02987/Japan Society for the Promotion of Science
- JP22H04923 (CoBiA)/Japan Society for the Promotion of Science
- JP22K08386/Japan Society for the Promotion of Science
- JP24K02317/Japan Society for the Promotion of Science
- JP20fk0108126/Japan Agency for Medical Research and Development
- JP20wm0325017/Japan Agency for Medical Research and Development
- JP21ck0106703/Japan Agency for Medical Research and Development
- JP23ck0106860/Japan Agency for Medical Research and Development
- JP23fk0108672/Japan Agency for Medical Research and Development
- JP23wm0325056/Japan Agency for Medical Research and Development
- JP24ama221534/Japan Agency for Medical Research and Development
LinkOut - more resources
Full Text Sources
Miscellaneous